The Centers for Disease Control and Prevention (CDC) National Center for Chronic Disease Prevention and Health Promotion has selected ICF (NASDAQ:ICFI), a global consulting and digital services provider, for a re-compete task order to continue its role in maintaining the National Program of Cancer Registries – Cancer Surveillance System (NPCR-CSS), one of the agency’s largest disease surveillance systems.
The task order, which was awarded in the third quarter, has a value of over $9 million and a term of four years including one base and three option years.
“Population-based cancer surveillance is playing an increasing role in informing cancer prevention and control interventions,” said David Cotton, senior vice president for ICF. “ICF is proud to serve as a trusted partner in helping CDC collect, aggregate and make sense of cancer data and of our involvement in a program that ultimately contributes to reducing the cancer burden in the U.S. population.”
ICF has helped CDC maintain the national cancer surveillance system since it was established in 2000. During this time, ICF has completed 18 consecutive national data submissions, collecting, processing and disseminating data on cancer occurrence, treatment and outcomes from now 49 state and territorial cancer registries across the United States.
Data collected under the NPCR-CSS today represents 97 percent of the U.S. population. When combined with the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program data, the entire U.S. population is represented. Both NPCR-CSS and SEER data are reported in the U.S. Cancer Statistics Incidence and Mortality Web-based Report, CDC’s official federal statistics on cancer incidence. This information enables researchers, clinicians, policy-makers, public health professionals and the public to monitor the burden of cancer, evaluate the successes of programs and identify additional needs for cancer prevention and control efforts at national, state and local levels.
Through this and other major disease surveillance work, ICF has assembled a seasoned team of experts with extensive experience in cancer and health data management, processing and quality validation; registry operations; and surveillance system design and architecture. These experts have cultivated long-standing working relationships with the individual state cancer registries and surveillance community at large. And they have the agility to accommodate the ever-changing data and security requirements and rapidly evolving technologies involved in this work.
ICF (NASDAQ:ICFI) is a global consulting services company with over 7,000 full- and part-time employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work together with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future. Learn more at icf.com.
Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to the government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; and our ability to acquire and successfully integrate businesses. These and other factors that could cause our actual results to differ from those indicated in forward-looking statements are included in the "Risk Factors" section of our securities filings with the Securities and Exchange Commission. The forward-looking statements included herein are only made as of the date hereof, and we specifically disclaim any obligation to update these statements in the future.